Objective: To validate a disease-specific health-related quality of life (H
RQOL) instrument for children with obstructive sleep disorders (OSDs).
Design: Prospective cohort study using a 6-item health-related instrument (
OSD-6).
Subjects: One hundred caregivers of patients with OSDs secondary to adenoto
nsillar hypertrophy (age range, 2-12 years) from 2 tertiary care, pediatric
otolaryngology practices.
Intervention: The OSD-6 was administered on initial presentation and 4 to 5
weeks after adenotonsillectomy. A subset of patients repeated the OSD-6 wi
thin 3 weeks after presentation to assess test-retest reliability.
Main Outcome Measures: Test-retest reliability, internal consistency, const
ruct validity, and responsiveness to clinical change of the OSD-6 score.
Results: Test-retest reliability was good (intraclass correlation coefficie
nt=0.74). Median OSD-6 score was 4.5 (0- to 6-point scale) with higher scor
es indicating poorer quality of life (QOL). Construct validity was demonstr
ated by the moderate correlation between OSD-6 score and global adenoid and
tonsil-related QOL (R=-0.62), strong correlation between the OSD-6 change
score and change in global adenoid and tonsil-related QOL (R=-0.63), and th
e moderate correlation between the change score and parent estimate of clin
ical change (R=0.40). The mean change in OSD-6 score after adenotonsillecto
my was 3.0 (95% confidence interval, 2.7-3.4). The mean standardized respon
se was 2.3 (95% confidence interval, 1.9-2.7) indicating the instrument's l
arge responsiveness to clinical change. The change score was very reliable
(R=0.85).
Conclusions: The OSD-6 is a reliable, responsive, easily administered instr
ument. It is valid for detecting change after adenotonsillectomy in childre
n with OSDs.